Aaron Alt
Chief Financial OfficerCardinal Health
CFOView Profile →Executive Vice President and Chief Financial Officer · Quest Diagnostics
Sam Samad is executive vice president and chief financial officer of Quest Diagnostics. His finance leadership spans pharmaceuticals, distribution, genomic technology and laboratory services, with operational experience in Canada and China.
Last reviewed: Nov 2, 2026
Executive Vice President and Chief Financial Officer
Quest Diagnostics
Last Reviewed: November 2, 2026
Sam Samad is executive vice president and chief financial officer of Quest Diagnostics. His finance leadership spans pharmaceuticals, distribution, genomic technology and laboratory services, with operational experience in Canada and China.
Samad spent 13 years at Eli Lilly in sales and finance roles in the United States and internationally, including chief financial officer of the company’s Canadian affiliate. His earlier career also included finance work at PepsiCo. He joined Cardinal Health in 2007 and held several senior finance assignments. These included senior vice president and chief financial officer of its pharmaceutical segment, a position he held from 2009 to 2012 in a business with approximately $85 billion in revenue during his tenure.
In February 2012, he became Cardinal Health’s senior vice president and corporate treasurer. Alongside treasury, he had operational and financial responsibility for the company’s China business. He held the treasury position until January 2017, when he moved to Illumina as chief financial officer. At the DNA-sequencing company, he oversaw finance, accounting, investor relations, internal audit and treasury.
Samad joined Quest Diagnostics in July 2022 as executive vice president and chief financial officer, with responsibility for the same core financial functions. In 2025, the company also placed LifeLabs under his responsibility. He serves on the board of IDEXX Laboratories, which he joined in July 2019.
Samad earned a BBA at the American University of Beirut in Lebanon and an MBA at McMaster University in Canada.